UK Markets closed

Allarity Therapeutics A/S (ALLR.ST)

Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
0.9295+0.0270 (+2.99%)
At close: 5:29PM CEST
Currency in SEK

Valuation measures

Market cap (intra-day) 5224.74M
Enterprise value 3222.83M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)1,549.91
Price/book (mrq)1.64
Enterprise value/revenue 31,536.73
Enterprise value/EBITDA 7-3.83

Trading information

Stock price history

Beta (5Y monthly) 0.63
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 32.1475
52-week low 30.6134
50-day moving average 30.9338
200-day moving average 30.8855

Share statistics

Avg vol (3-month) 33.61M
Avg vol (10-day) 34M
Shares outstanding 5241.78M
Implied shares outstanding 6N/A
Float 212.85M
% held by insiders 113.15%
% held by institutions 12.78%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in DKK.

Fiscal year

Fiscal year ends 31 Dec 2020
Most-recent quarter (mrq)31 Mar 2021


Profit margin 0.00%
Operating margin (ttm)-40,388.28%

Management effectiveness

Return on assets (ttm)-21.31%
Return on equity (ttm)-36.81%

Income statement

Revenue (ttm)145k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-36.35M
EBITDA -58.17M
Net income avi to common (ttm)-49.81M
Diluted EPS (ttm)-0.2680
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)663k
Total cash per share (mrq)0
Total debt (mrq)12.05M
Total debt/equity (mrq)8.78
Current ratio (mrq)0.35
Book value per share (mrq)0.57

Cash flow statement

Operating cash flow (ttm)-53.31M
Levered free cash flow (ttm)-38.77M